Launch One Acquisition Corp. has lost an independent director, leaving it short of Nasdaq’s requirements for both its audit committee and the proportion of independent directors on its board. The company plans to appoint a replacement, but had not done so as of Nov. 9.
Dr. Rodney A. Ferguson resigned from the board and its audit and compensation committees effective Nov. 4. The company said his departure did not stem from a disagreement over its operations, policies or practices.
Key details
- The audit committee now has two members, Atwood and Rogers, below Nasdaq’s minimum of three. The compensation committee also has two members, Atwood and Rogers.
- Ferguson’s departure also left the board without a majority of independent directors, another Nasdaq requirement.
- The company intends to use Nasdaq’s cure periods for both deficiencies. In general, those periods run until the earlier of the next annual shareholder meeting or one year after the vacancy; if the annual meeting is held within 180 days of the vacancy, the cure period is 180 days from the vacancy.
- The board intends to appoint an independent director who meets Nasdaq’s requirements to serve on both the board and audit committee. No replacement had been appointed as of Nov. 9, and the company gave no assurance about when one would be named.
- The report gives Nov. 6 as the date Nasdaq notified the company about the board’s lack of a majority of independent directors. It lists Dec. 6, 2026 as the notification date for the audit committee deficiency, although that date falls after the report’s Nov. 9 date.
What changes for investors
The disclosed issue is a governance and listing-compliance shortfall, not a change in the company’s stated business strategy or control. A qualifying independent director appointment is expected to address both board-composition problems. The company says it intends to rely on the available cure periods; the report does not announce a delisting.